New Zealand markets closed

Vyant Bio, Inc. (1C80.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.23200.0000 (0.00%)
At close: 08:02AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 3.55M
Enterprise value -2.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.93
Price/book (mrq)0.28
Enterprise value/revenue -3.04
Enterprise value/EBITDA 0.19

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3-93.29%
S&P500 52-week change 322.55%
52-week high 34.6000
52-week low 30.2080
50-day moving average 30.4490
200-day moving average 31.4791

Share statistics

Avg vol (3-month) 3107
Avg vol (10-day) 3500
Shares outstanding 56.27M
Implied shares outstanding 6N/A
Float 85.1M
% held by insiders 118.78%
% held by institutions 10.64%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,400.00%

Management effectiveness

Return on assets (ttm)-51.76%
Return on equity (ttm)-122.41%

Income statement

Revenue (ttm)397k
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)-27.90%
Gross profit (ttm)N/A
EBITDA -13.28M
Net income avi to common (ttm)-13.03M
Diluted EPS (ttm)-1.7200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.8M
Total cash per share (mrq)0.44
Total debt (mrq)708k
Total debt/equity (mrq)15.73%
Current ratio (mrq)2.86
Book value per share (mrq)0.71

Cash flow statement

Operating cash flow (ttm)-12.96M
Levered free cash flow (ttm)-9.42M